Zhumin Sun, Yang Zhang, Haiyan Zhou, Jingyun Li, Yue Zhou, Liyun Wang
{"title":"血清α-胰蛋白酶抑制剂重链 H4 可能是反映强直性脊柱炎疾病风险、活动性和治疗效果的抗炎标志物","authors":"Zhumin Sun, Yang Zhang, Haiyan Zhou, Jingyun Li, Yue Zhou, Liyun Wang","doi":"10.1080/00365513.2023.2250986","DOIUrl":null,"url":null,"abstract":"Interα-trypsin inhibitor heavy chain H4 (ITIH4) modulates inflammation and immunity, which take part in the pathogenesis of ankylosing spondylitis (AS). The current research intended to discover th...","PeriodicalId":501634,"journal":{"name":"Scandinavian Journal of Clinical and Laboratory Investigation","volume":"16 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-12-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Serum interα-trypsin inhibitor heavy chain H4 may be an anti-inflammatory marker reflecting disease risk, activity and treatment outcome of ankylosing spondylitis\",\"authors\":\"Zhumin Sun, Yang Zhang, Haiyan Zhou, Jingyun Li, Yue Zhou, Liyun Wang\",\"doi\":\"10.1080/00365513.2023.2250986\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Interα-trypsin inhibitor heavy chain H4 (ITIH4) modulates inflammation and immunity, which take part in the pathogenesis of ankylosing spondylitis (AS). The current research intended to discover th...\",\"PeriodicalId\":501634,\"journal\":{\"name\":\"Scandinavian Journal of Clinical and Laboratory Investigation\",\"volume\":\"16 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-12-29\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Scandinavian Journal of Clinical and Laboratory Investigation\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1080/00365513.2023.2250986\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Scandinavian Journal of Clinical and Laboratory Investigation","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/00365513.2023.2250986","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Serum interα-trypsin inhibitor heavy chain H4 may be an anti-inflammatory marker reflecting disease risk, activity and treatment outcome of ankylosing spondylitis
Interα-trypsin inhibitor heavy chain H4 (ITIH4) modulates inflammation and immunity, which take part in the pathogenesis of ankylosing spondylitis (AS). The current research intended to discover th...
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
